Spectrum of mutations in aspartylglucosaminuria.
- 15 December 1991
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 88 (24) , 11222-11226
- https://doi.org/10.1073/pnas.88.24.11222
Abstract
Aspartylglucosaminuria (AGU) is an inherited lysosomal storage disorder caused by the deficiency of aspartylglucosaminidase. We have earlier reported a single missense mutation (Cys163----Ser) to be responsible for 98% of the AGU alleles in the isolated Finnish population, which contains about 90% of the reported AGU patients. Here we describe the spectrum of 10 AGU mutations found in unrelated patients of non-Finnish origin. Since 11 out of 12 AGU patients were homozygotes, consanguinity has to be a common denominator in most AGU families. The mutations were distributed over the entire coding region of the aspartylglucosaminidase cDNA, except in the carboxyl-terminal 17-kDa subunit in which they were clustered within a 46-amino acid region. Based on the character of the mutations, most of them are prone to affect the folding and stability and not to directly affect the active site of the aspartylglucosaminidase enzyme.Keywords
This publication has 30 references indexed in Scilit:
- In vitro mutagenesis helps to unravel the biological consequences of aspartylglucosaminuria mutationGenomics, 1991
- Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. Amino acid substitution Cys163—-Ser abolishes the activity of lysosomal glycosylasparaginase and its conversion into subunitsJournal of Biological Chemistry, 1991
- Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structureBiochemical Journal, 1991
- Aspartylglycosaminuria in the Finnish population: identification of two point mutations in the heavy chain of glycoasparaginase.Proceedings of the National Academy of Sciences, 1991
- Glycosaparaginase from human leukocytes. Inactivation and covalent modification with diazo-oxonorvaline.Journal of Biological Chemistry, 1991
- A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein EGenomics, 1990
- ASPARTYLGLYCOSAMINURIA IN NORTHERN NORWAYThe Lancet, 1976
- Aspartylglucosaminuria: Psychomotor retardation masquerading as a mucopolysaccharidosisThe Journal of Pediatrics, 1975
- ASPARTYLGLYCOSAMINURIAThe Lancet, 1968
- Enzymatic cleavage of glycopeptidesBiochemical and Biophysical Research Communications, 1966